1.14
NanoViricides Inc (NNVC) 最新ニュース
Virtu Financial LLC Acquires New Position in NanoViricides, Inc. (NYSE:NNVC) - Defense World
Small cap wrap: NanoViricides, G Mining Ventures, Nevis Brands... - Proactive Investors
NanoViricides eyes role in US bird flu fight as USDA unveils $100M initiative - Proactive Investors
NanoViricides Has Initiated Bio-analytical Studies as Part of IND-Enabling Safety and Toxicology Studies of Lead Candidate NV-HHV-101 - ACCESS Newswire
NanoViricides (NYSE:NNVC) Trading Up 1.7% – Time to Buy? - Defense World
Stock Update - Investorsobserver
AllPennyStocks.com News: Junior Biotech Bounces off $1; Chart Trying to Turn Bullish - ACCESS Newswire
Market movers: Delta, Kohl's, Asana, NanoViricides... - Proactive Investors UK
NanoViricides says business unaffected by US tariffs, highlights antiviral pipeline - Proactive financial news
Nanoviricides Co's Business Not Affected By Tariff Policies Of Us Government Or Corresponding Retaliatory Policies Of Other Governments - Marketscreener.com
NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company - Jonesboro Sun
Springing into action in time of need: NanoViricides, Inc. (NNVC.OB) - ACCESS Newswire
Unicycive Therapeutics Inc (NASDAQ:UNCY) stock: Is this a flash in the pan today? - US Post News
Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan - Lelezard
NanoViricides' NV-387 could provide a crucial missing weapon in the fight against US measles outbreak - Proactive financial news
Investornewsbreaks Nanoviricides (NYSE American: NNVC) Highlights NV-387 As Potential Measles Treatment Amid Outbreak - MENAFN.COM
NanoViricides Announces Pricing of $10.2 Million Registered Direct Offering - ACCESS Newswire
Mpox – a possible US$100mln+ opportunity - Proactive Investors USA
NanoViricides Successfully Completes Required Genetic Toxicology Testing of Lead Drug Candidate NV-HHV-101 - ACCESS Newswire
NanoViricides to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am - ACCESS Newswire
NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2021Has Sufficient Cash, NV-CoV-2 Coronavirus Drug Candidate Clinical Trials Application Ready - ACCESS Newswire
NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2020Has Sufficient Cash, Progress on New Coronavirus Drug Program and the Lead HerpeCide(TM) Drug Candidate IND Application - ACCESS Newswire
NanoViricides Receives Cash Infusion of $2.25 Million - ACCESS Newswire
NanoViricides Closes on $8.625 Million Underwritten Public Offering of Common Stock - ACCESS Newswire
NanoViricides Has Initiated Required Safety Pharmacology Assessment of Lead Drug Candidate towards IND - ACCESS Newswire
Small cap headlines: EnWave, NanoViricides, GoviEx, TNR Gold... - Proactive Investors UK
NanoViricides targets key milestones in 2025 with NV-387 advancing to Phase II trials - Proactive Investors USA
NanoViricides, Inc. Has Filed its Quarterly Report - Chronicle-Tribune
NanoViricides, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2024 - Marketscreener.com
NanoViricides Inc. (NNVC) reports earnings - Quartz
NanoViricides: Fiscal Q2 Earnings Snapshot - San Antonio Express-News
NanoViricides: Fiscal Q2 Earnings Snapshot -February 14, 2025 at 04:38 pm EST - Marketscreener.com
Is NanoViricides Inc. (NNVC) the Best Nanotech Penny Stock to Invest In? - Insider Monkey
7 Best Nanotech Penny Stocks to Invest In - Insider Monkey
NanoViricides announces readiness to combat bird flu with antiviral drug NV-387 - Proactive Investors UK
NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape - Oil City Derrick
Powerful New Weapon Against Bird Flu: NanoViricides' Drug Outperforms Tamiflu in Lab Tests - StockTitan
NanoViricides Provides an Update on Its Clinical Program and StrategyNV-387 Could be As Revolutionary as Antibiotics - ACCESS Newswire
NanoViricides seeks to eliminate treatment delays with its broad spectrum antiviral NV-387 - Proactive Investors UK
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
NNVC’s price-to-cash ratio: Is it a good investment at the moment? - US Post News
NanoViricides warns of bird flu pandemic as outbreak spreads in Massachusetts - Proactive Investors USA
NanoViricides (NYSE:NNVC) Trading Down 1.8% – What’s Next? - Defense World
NanoViricides to present at MicroCap Conference 2025 in Atlantic City - Proactive Investors Australia
Game-Changing Antiviral Drug Shows 'Superior Results' Against Multiple Viruses$10B Market Potential - StockTitan
NanoViricides advances antiviral drug with Phase II Clinical trial to Combat MPox - Proactive Investors USA
大文字化:
|
ボリューム (24 時間):